ZA902307B - Carbonate derivatives of eseroline,a process for their preparation and their use as medicaments - Google Patents

Carbonate derivatives of eseroline,a process for their preparation and their use as medicaments

Info

Publication number
ZA902307B
ZA902307B ZA902307A ZA902307A ZA902307B ZA 902307 B ZA902307 B ZA 902307B ZA 902307 A ZA902307 A ZA 902307A ZA 902307 A ZA902307 A ZA 902307A ZA 902307 B ZA902307 B ZA 902307B
Authority
ZA
South Africa
Prior art keywords
eseroline
medicaments
preparation
carbonate derivatives
chem
Prior art date
Application number
ZA902307A
Other languages
English (en)
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA902307B publication Critical patent/ZA902307B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA902307A 1989-03-27 1990-03-26 Carbonate derivatives of eseroline,a process for their preparation and their use as medicaments ZA902307B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/329,171 US4971992A (en) 1989-03-27 1989-03-27 Carbonate derivatives of eseroline

Publications (1)

Publication Number Publication Date
ZA902307B true ZA902307B (en) 1990-12-28

Family

ID=23284183

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902307A ZA902307B (en) 1989-03-27 1990-03-26 Carbonate derivatives of eseroline,a process for their preparation and their use as medicaments

Country Status (18)

Country Link
US (1) US4971992A (es)
EP (1) EP0389984B1 (es)
JP (1) JPH0737458B2 (es)
KR (1) KR0163049B1 (es)
AT (1) ATE124044T1 (es)
AU (1) AU621208B2 (es)
CA (1) CA2013087C (es)
DE (1) DE69020205T2 (es)
DK (1) DK0389984T3 (es)
ES (1) ES2075081T3 (es)
FI (1) FI92932C (es)
HU (1) HU204053B (es)
IE (1) IE67449B1 (es)
IL (1) IL93895A (es)
NO (1) NO173995C (es)
NZ (1) NZ233065A (es)
PT (1) PT93535B (es)
ZA (1) ZA902307B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US5216017A (en) * 1990-05-11 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo[2,3-b]indole-ketones and analogs
AU634380B2 (en) * 1990-05-17 1993-02-18 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
AT404907B (de) * 1993-07-13 1999-03-25 Andritz Patentverwaltung Verfahren und anlage zum herstellen von edelstahlband
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
EP1604686A1 (en) * 2004-06-08 2005-12-14 Axonyx, Inc. Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
FI92932B (fi) 1994-10-14
FI92932C (fi) 1995-01-25
KR900014388A (ko) 1990-10-23
DE69020205D1 (de) 1995-07-27
EP0389984A1 (en) 1990-10-03
DE69020205T2 (de) 1995-12-07
AU621208B2 (en) 1992-03-05
AU5220290A (en) 1990-11-08
IL93895A0 (en) 1990-12-23
IE67449B1 (en) 1996-04-03
HU901832D0 (en) 1990-08-28
ES2075081T3 (es) 1995-10-01
KR0163049B1 (ko) 1998-12-01
JPH02289572A (ja) 1990-11-29
JPH0737458B2 (ja) 1995-04-26
NZ233065A (en) 1992-04-28
CA2013087C (en) 1999-12-28
NO173995C (no) 1994-03-02
IL93895A (en) 1995-07-31
ATE124044T1 (de) 1995-07-15
NO901385L (no) 1990-09-28
US4971992A (en) 1990-11-20
NO173995B (no) 1993-11-22
HUT54159A (en) 1991-01-28
PT93535A (pt) 1990-11-07
EP0389984B1 (en) 1995-06-21
DK0389984T3 (da) 1995-10-30
FI901470A0 (fi) 1990-03-23
HU204053B (en) 1991-11-28
CA2013087A1 (en) 1990-09-27
NO901385D0 (no) 1990-03-26
IE901097L (en) 1990-09-27
PT93535B (pt) 1996-03-29

Similar Documents

Publication Publication Date Title
ZA902307B (en) Carbonate derivatives of eseroline,a process for their preparation and their use as medicaments
CA2029265A1 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
FI102178B (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1, 3a,8-trimetyylipyrrolo£2,3-b|indol-5-yylijohdannaisten valmistamiseksi
HUT51597A (en) Process for production of derivatives of n,n-disubstituated diaryl-alcane-carbonic acid amid and medical compositions containing them as active substances